Could Common Medications Help People with Parkinson’s Live Longer? A New Study Suggests So

A recent Norwegian study has found something rather interesting—some everyday prescription drugs might help people with Parkinson’s live longer. Researchers looked at the medical records of over 14,000 people with Parkinson’s and tracked which medications they were prescribed after their diagnosis. Out of 219 different drugs, 23 were linked to a noticeably lower risk of death over an 8-year period. While that doesn’t mean these drugs cure Parkinson’s or officially slow the disease, it does suggest they might do something good—and could be worth studying more closely. So, what kind of drugs are we talking about? Surprisingly, they weren’t exotic or brand-new treatments. Some examples include: Cholesterol-lowering drugs like atorvastatin Blood pressure meds like losartan Antibiotics such as erythromycin and azithromycin Painkillers like codeine/paracetamol and tramadol Melatonin and zopiclone (used for sleep) Tadalafil (often prescribed for erectile dysfunction) Levothyroxine (a thyroid hormone) Anti-inflammatory drugs (NSAIDs) Mianserin, an antidepressant used in some countries Most of these weren’t originally intended for Parkinson’s at all. But they seem to have something in common—they influence mitochondria, the tiny power stations inside our cells. Mitochondrial problems are thought to play a big role in Parkinson’s, so it’s possible that supporting mitochondrial health could make a real difference over time. Could these meds be used to treat Parkinson’s? Not yet. The study didn’t test these drugs in a controlled trial, so it can’t say for sure that they caused the lower risk of death. But it opens the door to something called drug repurposing—taking safe, well-known medications and testing them for new uses, like treating Parkinson’s. Some of these drugs, like losartan and NSAIDs, have already shown hints of being helpful in past research. Others, like melatonin and macrolide antibiotics, are newer suggestions. Tadalafil and mianserin could be completely new candidates for future clinical trials. Any downsides? Yes—this was an observational study, which means it looked at patterns in real-world data but couldn’t control for everything. The researchers didn’t know exactly why people died, or whether they followed their prescriptions properly. Plus, some of the drugs might be helping indirectly—for example, reducing infections, pain, or stress, rather than treating Parkinson’s itself. Still, this is one of the biggest studies of its kind and it’s encouraging to see so many well-known drugs show potential. It also highlights how everyday health (like sleep, blood pressure, or gut health) can deeply influence long-term outcomes in Parkinson’s. What does this mean for you? You shouldn’t start or stop any medications based on this study—always speak to your doctor. But it’s worth asking whether your current prescriptions could be doing more than just their usual job. And it's another good reason to take care of your whole body, not just your brain. The big takeaway? Some familiar meds might hold clues to a longer, healthier life with Parkinson’s—and scientists are finally paying closer attention.